Molecular profile changes in castrate resistant prostate cancer patients pre and post-abiraterone/prednisone treatment.

Overview of attention for article published in Molecular Cancer Research, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 2,011)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 13 news outlets

twitter: 7 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 10,997 followers.

RT @MCR_AACR: From the December issue: Molecular Profile Changes in Patients with Castrate-Resistant #ProstateCancer Pre- and Post-Abirater…

19 Dec 2022

Reply Repost Favourite

From the December issue: Molecular Profile Changes in Patients with Castrate-Resistant #ProstateCancer Pre- and Post-Abiraterone/Prednisone Treatment, by Sicotte et al. https://t.co/NHaj41BSKS @MayoClinic https://t.co/WIlANsaiQt

19 Dec 2022

Reply Repost Favourite

06 Dec 2022

Reply Repost Favourite

Molecular profile changes in CRPC pts pre+post-Abiraterone/pred Tx | ✅Non-responders had low exp. of TGFBR3 and increased activation of the Wnt pathway, cell cycle, upreg. of AR variants, pre+post-Tx, w/ further del of AR inhibitor CDK11B post-Tx. https://

24 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.